Table 4.
Response genes in 9527 + oil treatment vs. control
| Ensembl ID | HGNC symbol | Raw p value | BH-adjusted p | log2 fold change |
|---|---|---|---|---|
| ENSG00000144810 | COL8A1 | 1.29E-12 | 1.72E-08 | −0.66 |
| ENSG00000128965 | CHAC1 | 5.03E-11 | 3.35E-07 | −0.74 |
| ENSG00000169174 | PCSK9 | 7.71E-11 | 3.42E-07 | −0.71 |
| ENSG00000104419 | NDRG1 | 7.04E-09 | 2.34E-05 | 0.62 |
| ENSG00000154678 | PDE1C | 1.80E-08 | 4.79E-05 | −0.59 |
| ENSG00000183691 | NOG | 1.56E-07 | 3.45E-04 | −0.61 |
| ENSG00000128342 | LIF | 2.53E-07 | 4.81E-04 | −0.60 |
| ENSG00000132003 | ZSWIM4 | 5.44E-07 | 7.93E-04 | −0.49 |
| ENSG00000106366 | SERPINE1 | 5.51E-07 | 7.93E-04 | −0.56 |
| ENSG00000142627 | EPHA2 | 5.96E-07 | 7.93E-04 | −0.42 |
| ENSG00000149090 | PAMR1 | 1.12E-06 | 1.36E-03 | −0.48 |
| ENSG00000137285 | TUBB2B | 1.65E-06 | 1.80E-03 | −0.37 |
| ENSG00000138764 | CCNG2 | 1.76E-06 | 1.80E-03 | 0.46 |
| ENSG00000138166 | DUSP5 | 4.17E-06 | 3.70E-03 | −0.54 |
| ENSG00000149571 | KIRREL3 | 5.40E-06 | 4.49E-03 | −0.50 |
| ENSG00000148677 | ANKRD1 | 6.12E-06 | 4.79E-03 | −0.50 |
| ENSG00000181649 | PHLDA2 | 1.10E-05 | 7.70E-03 | −0.42 |
| ENSG00000139178 | C1RL | 1.25E-05 | 8.32E-03 | 0.39 |
| ENSG00000123405 | NFE2 | 1.94E-05 | 1.23E-02 | 0.49 |
| ENSG00000149591 | TAGLN | 2.34E-05 | 1.41E-02 | −0.39 |
| ENSG00000224389 | C4B | 2.52E-05 | 1.41E-02 | 0.35 |
| ENSG00000159403 | C1R | 2.54E-05 | 1.41E-02 | 0.35 |
| ENSG00000155324 | GRAMD3 | 2.90E-05 | 1.54E-02 | −0.46 |
| ENSG00000112658 | SRF | 3.43E-05 | 1.75E-02 | −0.35 |
| ENSG00000169242 | EFNA1 | 3.97E-05 | 1.96E-02 | 0.42 |
| ENSG00000125726 | CD70 | 4.30E-05 | 2.04E-02 | −0.45 |
| ENSG00000113070 | HBEGF | 5.82E-05 | 2.67E-02 | −0.47 |
| ENSG00000107159 | CA9 | 6.24E-05 | 2.77E-02 | 0.45 |
| ENSG00000167470 | MIDN | 9.37E-05 | 3.89E-02 | −0.35 |
| ENSG00000106772 | PRUNE2 | 1.11E-04 | 4.49E-02 | −0.45 |
| ENSG00000160932 | LY6E | 1.39E-04 | 5.43E-02 | 0.31 |
| ENSG00000198910 | L1CAM | 1.61E-04 | 6.13E-02 | −0.43 |
| ENSG00000223749 | MIR503HG | 1.76E-04 | 6.52E-02 | −0.41 |
| ENSG00000149451 | ADAM33 | 2.00E-04 | 7.19E-02 | −0.36 |
| ENSG00000150782 | IL18 | 2.06E-04 | 7.21E-02 | −0.35 |
| ENSG00000205403 | CFI | 2.22E-04 | 7.30E-02 | 0.42 |
| ENSG00000120885 | CLU | 2.24E-04 | 7.30E-02 | −0.30 |
| ENSG00000225383 | SFTA1P | 2.25E-04 | 7.30E-02 | −0.37 |
| ENSG00000176171 | BNIP3 | 2.40E-04 | 7.59E-02 | 0.31 |
| ENSG00000113389 | NPR3 | 2.92E-04 | 9.05E-02 | −0.33 |
| ENSG00000261801 | LOXL1-AS1 | 3.07E-04 | 9.29E-02 | −0.36 |
| ENSG00000171617 | ENC1 | 3.35E-04 | 9.68E-02 | −0.36 |
| ENSG00000148700 | ADD3 | 3.41E-04 | 9.68E-02 | 0.34 |
| ENSG00000070756 | PABPC1 | 3.42E-04 | 9.68E-02 | 0.33 |
| ENSG00000187678 | SPRY4 | 3.61E-04 | 9.86E-02 | −0.39 |
| ENSG00000101443 | WFDC2 | 3.74E-04 | 9.94E-02 | 0.41 |
Note: Genes with symbols italicized are those that also responded to other treatments. PCSK9, KIRREL3, C1R, TAGLN, LY6E and WFDC2 are the response genes also for 9500 treatment. ZSWIM4, HBEGF and EPHA2 are the response genes also for oil treatment. PAMR1 and TUBB2B are the response genes also for oil and 9500 treatments. COL8A1 is the response gene also for 9500 and 9500+oil treatments.